These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31002164)

  • 1. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
    Su WZ; Ren LF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
    Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
    Pan DS; Cao P; Li JJ; Fan D; Song ZQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4254-4263. PubMed ID: 31173297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
    Li Y; Zhou HC; Zhang Y; Huang H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
    Wei YQ; Jiao XL; Zhang SY; Xu Y; Li S; Kong BH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7314-7326. PubMed ID: 31539118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
    Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircABCB10 promotes the proliferation and migration of lung cancer cells through down-regulating microRNA-217 expression.
    Hu TY; Zhu QX; Duan QY; Jin XY; Wu R
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6157-6165. PubMed ID: 32572881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
    He Y; Wu L; Dai Y; Li J; Liu S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.